# Mettler Toledo International Inc/: Form 10-Q for the period ended Mar 31, 2020

- Company: [Mettler Toledo International Inc/](/companies/mtd.md) (CIK 1037646)
- Form: 10-Q
- Filed: 2020-05-08
- Accepted by EDGAR: May 8, 2020, 09:07 ET
- Period: 2020-03-31
- Accession: 0001037646-20-000014
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1037646/000103764620000014/mtd10q3312020.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1037646/000103764620000014/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $649.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $374.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $34.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $198.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $10.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | $20.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | $98.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | $4.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | $4.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 24,353,477 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | $65.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $18.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2020-01-01 to 2020-03-31 | $200.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-03-31 | $323.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $1.20bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $2.89bn | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $679.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $2.58bn | us-gaap:Liabilities |
| Long-term debt | at 2020-03-31 | $1.51bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2020-03-31 | $306.4m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-03-31 | 23,907,528 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 30,281 characters.

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.*

### General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results to be expected for the full year ending December 31, 2020.

Changes in local currencies exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.

### COVID-19

The 2019 Coronavirus (COVID-19) pandemic has resulted in millions of confirmed cases throughout the world and in all countries where we conduct business. The outbreak has caused many governments to implement stay-at-home orders, quarantines and significant restrictions on travel. Several governments have also implemented work restrictions that prohibit many employees from going to their customary work locations and which require these employees to work remotely if possible. The quarantines, travel bans, work and other restrictions were initially put in place on a national level in China in January 2020, and with the global spread of the virus, subsequently adopted in other countries and regions throughout the first quarter with many restrictions commencing in Asia Pacific, Europe, North America, and Latin America.

The health and safety of our employees and business partners has been our highest priority throughout the COVID-19 pandemic, and we have implemented several preventative and protective measures relating to social distancing, hygiene, health monitoring, personal protective equipment, split shifts and remote work. We have also implemented business continuity plans and have been able to continue to support our customers with their essential businesses such as in life sciences, food manufacturing, chemicals (e.g. sanitizers, disinfectants, soaps etc.), food retail and transportation and logistics. Our production and logistics facilities are currently operational, and our office-based employees have been able to work remotely in adherence to applicable jurisdictional stay-at-home orders. Our supply chain is currently continuing with minimal interruption, and we currently maintain adequate product inventory levels and safety stock for certain components. We quickly adapted to leverage our digital and remote sales and service capabilities, while also meeting delivery requirements with our global supply chain. Our service organization also continues to provide on-site and remote customer support to facilitate uptime, productivity and regulatory compliance.

We have also implemented various temporary cost containment measures related to workforce management and discretionary spending. Our workforce management measures primarily include reduced work hours, salary freezes, and voluntary senior leadership salary reductions.

We maintain adequate liquidity consisting of approximately $342.9 million of additional borrowings available under our Credit Agreement, and $323.6 million of cash and cash equivalents as of March 31, 2020.

As further described in the Risk Factors section of this Form 10-Q, COVID-19 presents several risks to our business. For example, businesses can be shutdown, supply chains can be interrupted, slowed, or rendered inoperable, and individuals can become ill, quarantined, or otherwise unable to work and/or travel due to health reasons or governmental restrictions. COVID-19 also interferes with general commercial activity related to our supply chain and customer base. In addition, it is expected that COVID-19 will negatively affect the global economy and our customers' businesses, which will likely result in delayed or reduced purchases from us. Some customers may also have difficulty meeting their payment obligations to us, resulting in late payments or an inability of some customers to make payments at all.

During the three months ended March 31, 2020, COVID-19 had a negative impact on our business, primarily related to reduced customer demand in China as well as in other regions. With the global spread of the virus and related negative impact to the global economy, we expect reduced global sales volume due to lower customer demand in future quarters. The longer-term effects on our business will be impacted by the global economy and any recession implications in different regions of the world. While it is extremely difficult to estimate the extent and duration of any COVID-19 implications, the effects on our business, results of operations and financial condition could be material.

### Results of Operations – Consolidated

The following tables set forth items from our interim consolidated statements of operations and comprehensive income for the three month periods ended March 31, 2020 and 2019 (amounts in thousands).

|  | Three months ended March 31, 2020 (unaudited)% |  | 2019 (unaudited)% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $649,162 | 100.0 | $679,452 | 100.0 |
| Cost of sales | 274,753 | 42.3 | 291,133 | 42.8 |
| Gross profit | 374,409 | 57.7 | 388,319 | 57.2 |
| Research and development | 34,387 | 5.3 | 36,053 | 5.3 |
| Selling, general and administrative | 198,744 | 30.6 | 204,425 | 30.1 |
| Amortization | 13,998 | 2.2 | 12,222 | 1.8 |
| Interest expense | 10,219 | 1.6 | 9,094 | 1.3 |
| Restructuring charges | 1,905 | 0.3 | 1,523 | 0.2 |
| Other charges (income), net | (3,343) | (0.5) | (674) | — |
| Earnings before taxes | 118,499 | 18.2 | 125,676 | 18.5 |
| Provision for taxes | 20,384 | 3.1 | 13,871 | 2.0 |
| Net earnings | $98,115 | 15.1 | $111,805 | 16.5 |

#### Net sales

Net sales were $649.2 million for the three months ended March 31, 2020, compared to $679.5 million for the corresponding period in 2019. This represents a decrease in U.S. dollars of 4%. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales decreased 3% for the three months ended March 31, 2020. Net sales were negatively impacted by the COVID-19 pandemic and related reduction in customer demand on our operations in China as well as in other regions. Net sales were also reduced by a decline in food retailing. We expect net sales in local currencies will be adversely affected by the COVID-19 pandemic related to unfavorable economic conditions and reduced customer demand in future quarters.

Net sales by geographic destination for the three months ended March 31, 2020 in U.S. dollars increased 2% in the Americas and decreased 7% Europe and 10% in Asia/Rest of World. In local currencies, our net sales by geographic destination increased 3% in the Americas and decreased 5% in Europe and 8% in Asia/Rest of World. Net sales in Asia/Rest of World were reduced by 7% in U.S. dollars and 6% in local currencies for the three months ended March 31, 2020 due to a 13% local currency sales decline versus the prior year comparable period in China. As previously mentioned, net sales in China and other regions were negatively impacted by reduced customer demand due to COVID-19. A discussion of sales by operating segment is included below.

As described in Note 19 to our consolidated financial statements for the year ended December 31, 2019, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products decreased 7% in U.S. dollars and 5% in local currency for the three months ended March 31, 2020 compared to the prior period. Service revenue (including spare parts) increased 3% in U.S. dollars and 5% in local currency during the three months ended March 31, 2020 compared to the corresponding period in 2019.

Net sales of our laboratory products and services, which represented approximately 55% of our total net sales for the three months ended March 31, 2020, decreased 1% in U.S. dollars and increased 1% in local currencies during the three months ended March 31, 2020. The local currency increase in net sales of our laboratory-related products includes strong growth in pipettes and automated chemistry, offset in part by decreases in other product categories.

Net sales of our industrial products and services, which represented approximately 39% of our total net sales for the three months ended March 31, 2020, decreased 7% in U.S. dollars and 5% in local currencies during the three months ended March 31, 2020. The local currency decrease in net sales of our industrial-related products for the three months ended March 31, 2020 includes declines in core industrial and product inspection. Industrial-related products included a significant decline in China related to reduced customer demand due to COVID-19.

Net sales in our food retailing products and services, which represented approximately 6% of our total net sales for the three months ended March 31, 2020, decreased 18% in U.S. dollars and 16% in local currencies during the three months ended March 31, 2020. The decline in food retailing is primarily due to unfavorable market conditions and the timing of project activity.

#### Gross profit

Gross profit as a percentage of net sales was 57.7% for the three months ended March 31, 2020 compared to 57.2% for the corresponding period in 2019.

Gross profit as a percentage of net sales for products was 60.8% and 59.9% for the three month periods ended March 31, 2020 and 2019.

Gross profit as a percentage of net sales for services (including spare parts) was 48.0% for the three months ended March 31, 2020 compared to 47.8% for the corresponding period in 2019.

The increase in gross profit as a percentage of net sales for the three months ended March 31, 2020 primarily reflects favorable price realization and material cost reductions.

#### Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales was 5.3% for both the three months ended March 31, 2020 and 2019, respectively. Research and development expenses decreased 5% in both U.S. dollars and in local currencies, during the three months ended March 31, 2020 compared to the corresponding period in 2019. This decrease relates to the timing of project activity as research and development expenses increased 9% in local currencies during the three months ended March 31, 2019 versus the prior year comparable period.

Selling, general and administrative expenses as a percentage of net sales were 30.6% for the three months ended March 31, 2020 compared to 30.1% in the corresponding period during 2019. Selling, general and administrative expenses decreased 3% in U.S. dollars and 2% in local currencies, during the three months ended March 31, 2020 compared to the corresponding period in 2019. The local currency decrease includes benefits from our cost savings initiatives and lower cash incentive expense.

#### Amortization, interest expense, other charges (income), net and taxes

Amortization expense was $14.0 million for the three months ended March 31, 2020 and $12.2 million for the corresponding period in 2019.

Interest expense was $10.2 million for the three months ended March 31, 2020 and $9.1 million for the corresponding period in 2019.

Other charges (income), net includes non-service pension costs (benefits), net (gains) losses from foreign currency transactions and hedging activities, interest income and other items. Non-service pension benefits for the three months ended March 31, 2020 and 2019 were $3.0 million and $1.2 million, respectively.

Our reported tax rate was 17% and 11% during the three months ended March 31, 2020 and 2019, respectively. The provision for taxes is based upon using our projected annual effective tax rate of 21.5% and 20.5% before non-recurring discrete tax items for the three months ended March 31, 2020 and 2019, respectively. The difference between our projected annual effective tax rate and the reported tax rate is related to the timing of excess tax benefits associated with stock option exercises.

### Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 19 to our consolidated financial statements for the year ended December 31, 2019.

#### U.S. Operations (amounts in thousands)

|  | Three months ended March 31, |  |
| --- | ---: | ---: |
|  | 2020 | 2019% |
| Total net sales | $267,800 | $260,795 3% |
| Net sales to external customers | $241,409 | $234,650 3% |
| Segment profit | $44,938 | $37,985 18% |

Total net sales and net sales to external customers both increased 3%, respectively for the three months ended March 31, 2020 compared with the corresponding period in 2019. The increase in total net sales and net sales to external customers for the three months ended March 31, 2020 includes strong growth in core industrial and good growth in laboratory products, partially offset by declines in food retailing and product inspection.

Segment profit increased $7.0 million for the three months ended March 31, 2020 compared to the corresponding period in 2019. Segment profit during the three months ended March 31, 2020 includes higher net sales volume and benefits from our margin expansion and cost savings initiatives.

#### Swiss Operations (amounts in thousands)

|  | Three months ended March 31, 2020 | 2019 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $184,745 | $187,308 | (1)% |
| Net sales to external customers | $31,897 | $33,577 | (5)% |
| Segment profit | $53,910 | $53,522 | 1% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales decreased 1% in U.S. dollars and 4% in local currency for the three months ended March 31, 2020 compared to the corresponding period in 2019. Net sales to external customers decreased 5% in U.S. dollars and 7% in local currency during the three months ended March 31, 2020 compared to the corresponding period in 2019 and included declines in most product categories. This compares to strong local currency sales growth of 7% for the three months ended March 31, 2019. The decrease in sales to external customers also reflects reduced customer demand related to the COVID-19 pandemic.

Segment profit increased $0.4 million for the three month period ended March 31, 2020 compared to the corresponding period in 2019. Segment profit during the three months ended March 31, 2020 includes benefits of our cost savings initiatives and the timing of research and development activity, offset in part by lower net sales volume and unfavorable foreign currency translation.

#### Western European Operations (amounts in thousands)

|  | Three months ended March 31, 2020 | 2019 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $195,040 | $209,951 | (7)% |
| Net sales to external customers | $153,325 | $165,906 | (8)% |
| Segment profit | $24,107 | $25,725 | (6)% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales decreased 7% in U.S. dollars and 4% in local currencies during the three months period ended March 31, 2020 compared to the corresponding period in 2019. Net sales to external customers decreased 8% in U.S. dollars and 5% in local currencies during the three months period ended March 31, 2020 compared to the corresponding period in 2019 and included declines in industrial products and food retailing. This compares to strong local currency sales growth of 9% for the three months ended March 31, 2019 as compared to the prior year comparable period. The decrease in local currency net sales to external customers for the three months ended March 31, 2020 also reflects reduced customer demand related to the COVID-19 pandemic.

Segment profit decreased $1.6 million for the three month period ended March 31, 2020 compared to the corresponding period in 2019. Segment profit decreased during the three months ended March 31, 2020 primarily due to the decline in net sales and unfavorable foreign currency translation, offset in part by benefits from our margin expansion and cost savings initiatives.

#### Chinese Operations (amounts in thousands)

|  | Three months ended March 31, 2020 | 2019 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $149,348 | $178,580 | (16)% |
| Net sales to external customers | $100,599 | $121,723 | (17)% |
| Segment profit | $45,550 | $59,484 | (23)% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales decreased 16% in U.S. dollars and 14% in local currency for the three months ended March 31, 2020 compared to the corresponding period in 2019. Net sales to external customers by origin decreased 17% in U.S. dollars and 15% in local currency during the three months ended March 31, 2020 compared to the corresponding period in 2019. The decrease in local currency net sales to external customers during the three months ended March 31, 2020 reflects declines in most product categories, particularly industrial products and food retailing, from lower customer demand due to the COVID-19 pandemic. Governmental restrictions related to COVID-19 have been removed and we are currently experiencing increased business activity. However, significant uncertainty remains relating to COVID-19 and the local Chinese economy, and market conditions may change quickly, especially if the government should re-impose travel or workplace restrictions.

Segment profit decreased $13.9 million for the three month period ended March 31, 2020 compared to the corresponding period in 2019. The decrease in segment profit for the three month period ended March 31, 2020 primarily reflects the decline in net sales as well as unfavorable foreign currency translation, offset in part by our cost savings initiatives.

#### Other (amounts in thousands)

|  | Three months ended March 31, 2020 | 2019 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $122,828 | $124,857 | (2)% |
| Net sales to external customers | $121,932 | $123,596 | (1)% |
| Segment profit | $11,026 | $13,187 | (16)% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales decreased 2% in U.S. dollars and was flat in local currencies during the three month period ended March 31, 2020 compared to the corresponding period in 2019. Total net sales to external customers decreased 1% in U.S. dollars and increased 1% in local currencies during the three month period ended March 31, 2020 compared to the corresponding period in 2019. The increase in net sales to external customers includes mixed results with certain regions experiencing reduced customer demand related to COVID-19.

Segment profit decreased $2.2 for the three months ended March 31, 2020 compared to the corresponding period in 2019. The decrease in segment profit is primarily related to unfavorable foreign currency translation and business mix.

### Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes available borrowings under our Credit Agreement, the ability to obtain appropriate financing and our cash and cash equivalent balances. Currently, our liquidity needs are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $65.5 million during the three months ended March 31, 2020, compared to $98.8 million in the corresponding period in 2019. The decrease in 2020 includes higher tax payments of approximately $13 million. Changes in inventories also reduced cash flow during the three months ended March 31, 2020 versus the prior year comparable period by approximately $8 million as we increased inventory levels given uncertainties related to potential COVID-19 implications on our global supply chain. Cash flow provided by operating activities was also reduced by our lower net earnings as compared to the prior year period.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $18.8 million for the three months ended March 31, 2020 compared to $22.3 million in the corresponding period in 2019. We expect to make net investments in new or expanded manufacturing facilities of $15 million to $20 million over the next two years.

#### Senior Notes and Credit Facility Agreement

Our debt consisted of the following at March 31, 2020:

|  | March 31, 2020 U.S. Dollar | Other Principal Trading Currencies | Total |
| --- | ---: | ---: | ---: |
| 3.67% $50 million ten-year Senior Notes due December 17, 2022 | $50,000 | $— | $50,000 |
| 4.10% $50 million ten-year Senior Notes due September 19, 2023 | 50,000 | — | 50,000 |
| 3.84% $125 million ten-year Senior Notes due September 19, 2024 | 125,000 | — | 125,000 |
| 4.24% $125 million ten-year Senior Notes due June 25, 2025 | 125,000 | — | 125,000 |
| 3.91% $75 million ten-year Senior Notes due June 25, 2029 | 75,000 | — | 75,000 |
| 3.19% $50 million fifteen-year Senior Notes due January 24, 2035 | 50,000 | — | 50,000 |
| 1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030 | — | 139,229 | 139,229 |
| 1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034 | — | 150,368 | 150,368 |
| Senior notes debt issuance costs, net | (1,106) | (1,126) | (2,232) |
| Total Senior Notes | 473,894 | 288,471 | 762,365 |
| $1.1 billion Credit Agreement, interest at LIBOR plus 87.5 basis points | 668,997 | 81,425 | 750,422 |
| Other local arrangements | 1,286 | 55,345 | 56,631 |
| Total debt | 1,144,177 | 425,241 | 1,569,418 |
| Less: current portion | (1,053) | (55,345) | (56,398) |
| Total long-term debt | $1,143,124 | $369,896 | $1,513,020 |

As of March 31, 2020, approximately $342.9 million of additional borrowings was available under our Credit Agreement, and we maintained $323.6 million of cash and cash equivalents. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates. Further, we do not have any downgrade triggers relating to ratings from rating agencies that would accelerate the maturity dates of our debt.

We currently believe that cash flow from operating activities, together with liquidity available under our Credit Agreement and local working capital facilities and our cash balances, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for the foreseeable future.

On January 24, 2020, we issued $50 million fifteen-year Senior notes with a fixed interest rate of 3.19%, which will mature January 24, 2035. The terms of the Senior Notes are consistent with the previous issued Senior Notes as described in our Annual Report on Form 10-K for the year ended December 31, 2019. We used the proceeds from the sale of the notes to refinance existing indebtedness and for other general corporate purposes.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. During the three months ended March 31, 2019, we paid $10 million related to the settlement of the Biotix acquisition contingent consideration as further described in Note 4 of our Annual Report on Form 10-K for the year ended December 31, 2019.

In 2018, two of the Company's non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions which include an interest rate of Swiss franc LIBOR plus 87.5 basis points. The loans were renewed for one year in April 2020.

#### Share Repurchase Program

In November 2018, the Company's Board of Directors authorized an additional $2.0 billion to the share repurchase program which has $1.1 billion of remaining availability as of March 31, 2020. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity, and other factors.

We have purchased 28.9 million common shares since the inception of the program in 2004 through March 31, 2020. During both the three months ended March 31, 2020 and 2019, we spent $200.0 million and $186.3 million on the repurchase of 268,161 shares and 290,429 shares at an average price per share of $745.80 and $641.27, respectively. We reissued 50,372 shares and 171,752 shares held in treasury for the exercise of stock options and restricted stock units during the three months ended March 31, 2020 and 2019, respectively.

### Effect of Currency on Results of Operations

Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings decrease. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also decrease. We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.6 million to $1.8 million annually.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $1.7 million to $1.9 million annually.

In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at March 31, 2020, we estimate that a 5% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $22.4 million in the reported U.S. dollar value of our debt.

### Forward-Looking Statements Disclaimer

*You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth and long-term impacts of the COVID-19 pandemic. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue.”*

*We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, customer demand, our competitive position, pricing, our supply chain, adequacy of our facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, planned research and development efforts and product introductions, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of the COVID-19 pandemic on our businesses.*

*Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including the uncertain duration and severity of the COVID-19 pandemic. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2019 and other reports filed with the SEC from time to time.*

## Market risk

As filed, 174 characters.

As of March 31, 2020, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

## Controls and procedures

As filed, 702 characters.

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended March 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 3,427 characters.

For the three months ended March 31, 2020 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 except the following update.

*The COVID-19 outbreak has and will likely continue to negatively affect various aspects of our business, including our workforce and supply chain, and make it more difficult and expensive to meet our obligations to our customers, and has and will likely continue to result in reduced demand from our customers as their businesses may also be negatively affected.*

Our global operations are susceptible to global events that could have an adverse effect on our business results and financial condition.

For instance, we are susceptible to a widespread outbreak of an illness or other health issue, such as the ongoing 2019 Coronavirus outbreak ("COVID-19"), and which now has since spread globally, resulting in millions of confirmed cases throughout the world and in all countries where we conduct business. The outbreak has caused many governments to implement stay-at-home orders, quarantines and significant restrictions on travel. Several governments have also implemented work restrictions that prohibit many employees from going to their customary work locations and which require these employees to work remotely if possible. The quarantines, travel bans, work and other restrictions were initially put in place on a national level in China in January 2020, and with the global spread of the virus, subsequently adopted in many other countries and regions throughout the first quarter with many restrictions commencing in Asia Pacific, Europe, North America and Latin America.

As a result of pandemic outbreaks, including COVID-19, businesses can be shut down, supply chains can be interrupted, slowed, or rendered inoperable, and individuals can become ill, quarantined, or otherwise unable to work and/or travel due to health reasons or governmental restrictions. COVID-19 interferes with general commercial activity related to our supply chain and customer base. In addition, it is expected that COVID-19 will negatively affect the global economy and our customers' businesses, which will result in delayed or reduced purchases from us. Some customers may also have difficulty meeting their payment obligations to us, resulting in late payments or an inability of some customers to make payments at all.

During the three months ended March 31, 2020, COVID-19 had a negative impact on our business, primarily related to reduced customer demand in China as well as in other regions. With the global spread of the virus and related negative impact to the global economy, we expect reduced global sales volume from lower customer demand in future quarters. Our operations could be negatively affected further if our employees who are currently not subject to stay-at-home or work restriction orders are quarantined or become ill as a result of exposure to COVID-19, or if they become subject to governmental COVID-19 curfews or stay-at-home orders. The longer-term effects on our business will be impacted by the global economy and any recession implications in different regions of the world. While it is extremely difficult to estimate the extent and duration of any COVID-19 implications, the effects on our business, results of operations and financial condition could be material.

Filed May 8, 2020.
Source: SEC EDGAR, the filing index for accession 0001037646-20-000014. Last ingested by Listed: Nov 13, 2026, 02:43 ET. No prices; not investment advice.
